Evidence map›Paper›PMID 25269804›Full record

ArticleCarcinogenesis2014

Carcinogenicity and DNA adduct formation of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone and enantiomers of its metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in F-344 rats.

Silvia Balbo, Charles S Johnson, Ramesh C Kovi, Sandra A James-Yi, M Gerard O'Sullivan, Mingyao Wang, Chap T Le, Samir S Khariwala, Pramod Upadhyaya, Stephen S Hecht

Open access · bronzeAbstract read
In one paragraph

Article in Carcinogenesis, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
1.9field-weighted citation impact, top 15% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 49 citations in OpenAlex.

  1. Trial
  2. Review
  3. Review
  4. Opportunities and Challenges of Kava in Lung Cancer Prevention.International journal of molecular sciences · 2023
    Review
  5. DNA Alkylation Damage by Nitrosamines and Relevant DNA Repair Pathways.International journal of molecular sciences · 2023
    Review
  6. Article
  7. Metabolism and DNA Adduct Formation of Tobacco-SpecificInternational journal of molecular sciences · 2022
    Review
  8. Article
  9. Review
  10. Identification of anChemical research in toxicology · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Biochemical Verification of Tobacco Use and Abstinence: 2019 Update.Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco · 2020
    Review
  15. Article
  16. Article
  17. Article
  18. DNA replication studies ofThe Journal of biological chemistry · 2019
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Silvia BalboMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Charles S JohnsonMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Ramesh C KoviMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Sandra A James-YiMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
M Gerard O'SullivanMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Mingyao WangMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Chap T LeMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Samir S KhariwalaMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Pramod UpadhyayaMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA.
Stephen S HechtMasonic Cancer Center, University of Minnesota, Minneapolis, MN 55455, USA hecht002@umn.edu.
University of Minnesota Medical Center · US

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Douglas Yee · 1998 to 2026
$100.4M
METABOLISM OF CARCINOGENIC TOBACCO SPECIFIC NITROSAMINESR01CA081301 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI STEPHEN S HECHT · 1999 to 2026
$7.1M
Metabolism of Carcinogenic Tobacco-Specific NitrosaminesR37CA081301 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI HECHT, STEPHEN S · 2004 to 2013
$5.5M
Tobacco carcinogens as markers of exposure, carcinogenesis and risk in oral canceK23DE023572 · NIDCR · UNIVERSITY OF MINNESOTA · PI KHARIWALA, SAMIR S · 2013 to 2017
$681k
NCI NIH HHS CA-81301NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA081301NIDCR NIH HHS K23 DE023572
6 · The paper itself

Abstract

4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) is metabolized to enantiomers of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL), found in the urine of virtually all people exposed to tobacco products. We assessed the carcinogenicity in male F-344 rats of (R)-NNAL (5 ppm in drinking water), (S)-NNAL (5 ppm), NNK (5 ppm) and racemic NNAL (10 ppm) and analyzed DNA adduct formation in lung and pancreas of these rats after 10, 30, 50 and 70 weeks of treatment. All test compounds induced a high incidence of lung tumors, both adenomas and carcinomas. NNK and racemic NNAL were most potent; (R)-NNAL and (S)-NNAL had equivalent activity. Metastasis was observed from primary pulmonary carcinomas to the pancreas, particularly in the racemic NNAL group. DNA adducts analyzed were O (2)-[4-(3-pyridyl)-4-oxobut-1-yl]thymidine (O (2)-POB-dThd), 7-[4-(3-pyridyl)-4-oxobut-1-yl]guanine(7-POB-Gua),O (6)-[4-(3-pyridyl)-4-oxobut-1-yl]deoxyguanosine(O (6)-POB-dGuo),the 4-(3-pyridyl)-4-hydroxybut-1-yl(PHB)adductsO (2)-PHB-dThd and 7-PHB-Gua, O (6)-methylguanine (O (6)-Me-Gua) and 4-hydroxy-1-(3-pyridyl)-1-butanone (HPB)-releasing adducts. Adduct levels significantly decreased with time in the lungs of rats treated with NNK. Pulmonary POB-DNA adducts and O (6)-Me-Gua were similar in rats treated with NNK and (S)-NNAL; both were significantly greater than in the (R)-NNAL rats. In contrast, pulmonary PHB-DNA adduct levels were greatest in the rats treated with (R)-NNAL. Total pulmonary DNA adduct levels were similar in (S)-NNAL and (R)-NNAL rats. Similar trends were observed for DNA adducts in the pancreas, but adduct levels were significantly lower than in the lung. The results of this study clearly demonstrate the potent pulmonary carcinogenicity of both enantiomers of NNAL in rats and provide important new information regarding DNA damage by these compounds in lung and pancreas.

Indexed as

AdenocarcinomaAdenomaAnimalsApoptosisCarcinogensChromatography, High Pressure LiquidDNA AdductsDNA DamageHumansLung NeoplasmsMaleNitrosaminesPancreatic NeoplasmsProhibitinsPyridinesRats4-(methylnitrosamino)-1-(3-pyridyl)-1-butan-1-ol4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanoneCarcinogensDNA AdductsNitrosaminesPHB protein, humanPhb protein, ratProhibitinsPyridines

Identifiers

PMID25269804
PMCPMC4247520
OpenAlexW2110221796

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.